AS Latvijas Juras medicinas centrs (RSE:LJM1R)
Latvia
· Delayed Price · Currency is EUR 7.85
-0.05 (-0.63%)
At close: Mar 6, 2026
RSE:LJM1R Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 10.29 | 10.19 | 9.85 | 9.7 | 9.36 | Upgrade
|
| Revenue Growth (YoY) | 0.98% | 3.42% | 1.54% | 3.60% | 32.24% | Upgrade
|
| Cost of Revenue | 9.55 | 9.46 | 9.08 | 8.53 | 7.77 | Upgrade
|
| Gross Profit | 0.73 | 0.72 | 0.77 | 1.17 | 1.6 | Upgrade
|
| Selling, General & Admin | 0.76 | 0.69 | 0.67 | 0.71 | 0.58 | Upgrade
|
| Other Operating Expenses | -0.29 | -0.15 | 0.17 | -0.17 | 0.14 | Upgrade
|
| Operating Expenses | 0.48 | 0.55 | 0.84 | 0.54 | 0.72 | Upgrade
|
| Operating Income | 0.26 | 0.18 | -0.07 | 0.63 | 0.88 | Upgrade
|
| EBT Excluding Unusual Items | 0.26 | 0.18 | -0.07 | 0.63 | 0.88 | Upgrade
|
| Asset Writedown | - | - | -0.55 | - | - | Upgrade
|
| Pretax Income | 0.26 | 0.18 | -0.62 | 0.63 | 0.88 | Upgrade
|
| Income Tax Expense | 0.02 | - | 0 | 0 | 0 | Upgrade
|
| Earnings From Continuing Operations | 0.24 | 0.18 | -0.62 | 0.63 | 0.88 | Upgrade
|
| Net Income | 0.24 | 0.18 | -0.62 | 0.63 | 0.88 | Upgrade
|
| Net Income to Common | 0.24 | 0.18 | -0.62 | 0.63 | 0.88 | Upgrade
|
| Net Income Growth | 35.23% | - | - | -28.92% | 221.78% | Upgrade
|
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| EPS (Basic) | 0.30 | 0.22 | -0.78 | 0.78 | 1.10 | Upgrade
|
| EPS (Diluted) | 0.30 | 0.22 | -0.78 | 0.78 | 1.10 | Upgrade
|
| EPS Growth | 35.23% | - | - | -28.92% | 221.79% | Upgrade
|
| Free Cash Flow | 0.39 | 0.19 | -0.57 | 0.46 | -0.69 | Upgrade
|
| Free Cash Flow Per Share | 0.49 | 0.24 | -0.71 | 0.58 | -0.86 | Upgrade
|
| Dividend Per Share | - | 0.100 | - | - | 0.200 | Upgrade
|
| Dividend Growth | - | - | - | - | 185.71% | Upgrade
|
| Gross Margin | 7.13% | 7.12% | 7.83% | 12.05% | 17.07% | Upgrade
|
| Operating Margin | 2.51% | 1.75% | -0.74% | 6.46% | 9.41% | Upgrade
|
| Profit Margin | 2.34% | 1.75% | -6.34% | 6.45% | 9.40% | Upgrade
|
| Free Cash Flow Margin | 3.78% | 1.86% | -5.75% | 4.78% | -7.39% | Upgrade
|
| EBITDA | 0.88 | 0.8 | 0.48 | 1.05 | 1.17 | Upgrade
|
| EBITDA Margin | 8.55% | 7.85% | 4.86% | 10.87% | 12.47% | Upgrade
|
| D&A For EBITDA | 0.62 | 0.62 | 0.55 | 0.43 | 0.29 | Upgrade
|
| EBIT | 0.26 | 0.18 | -0.07 | 0.63 | 0.88 | Upgrade
|
| EBIT Margin | 2.51% | 1.75% | -0.74% | 6.46% | 9.41% | Upgrade
|
| Effective Tax Rate | 6.69% | - | - | 0.10% | 0.07% | Upgrade
|
| Advertising Expenses | - | 0.03 | 0.02 | 0.01 | 0 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.